Gilead Sciences Earnings: Here’s Why Shares are Down Now

Gilead Sciences Inc. (NASDAQ:GILD) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are down 0.34%.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

Gilead Sciences Inc. Earnings Cheat Sheet

Results: Adjusted Earnings Per Share increased 4.35% to $0.48 in the quarter versus EPS of $0.46 in the year-earlier quarter.

Revenue: Rose 10.92% to $2.53 billion from the year-earlier quarter.

Actual vs. Wall St. Expectations: Gilead Sciences Inc. reported adjusted EPS income of $0.48 per share. By that measure, the company missed the mean analyst estimate of $0.50. It missed the average revenue estimate of $2.58 billion.

Quoting Management: There was no comment from management.

Key Stats (on next page)…

Revenue decreased 2.19% from $2.59 billion in the previous quarter. EPS decreased 4% from $0.50 in the previous quarter.

Looking Forward: Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.53 to a profit $0.50. For the current year, the average estimate has moved down from a profit of $2.17 to a profit of $2.02 over the last ninety days.

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)